PETRUS: Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris (Other)

Overall Status

Completed

CT.gov ID

NCT01786031

Collaborator

(none)

Enrollment

Location

Arm

Duration (Months)

2.2

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Toward personalised treatment in early metastatic prostate cancer based on the assessment of biomarkers in cancer tissue samples and circulating tumour cells.

Condition or Disease	Intervention/Treatment	Phase
Metastatic Castration Resistant Prostate Cancer Patients	Other: metastasis biopsy	N/A

Study Design

Study Type:

Interventional

Actual Enrollment :

55 participants

Allocation:

N/A

Intervention Model:

Single Group Assignment

Masking:

None (Open Label)

Primary Purpose:

Diagnostic

Official Title:

Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program

Study Start Date :

Dec 1, 2012

Actual Primary Completion Date :

Jan 1, 2015

Actual Study Completion Date :

Jan 1, 2015

Arms and Interventions

Arm	Intervention/Treatment
Experimental: experimental metastasis biopsy	Other: metastasis biopsy

Arm

Intervention/Treatment

Experimental: experimental

metastasis biopsy

Other: metastasis biopsy

Outcome Measures

Primary Outcome Measures

Biomarker [assessed at the end of recruitment, up to 2 years]
success to evaluate at least one molecular analysis in tumor tissues (prostate and/or metastatic site) AND in CTC

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

Male

Accepts Healthy Volunteers:

Inclusion Criteria:

Prostate Cancer patients
Castration Resistant
Prostatic tissue available
Metastasis which may be biopsied

Exclusion Criteria:

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Institut Gustave Roussy	Villejuif	Val de Marne	France	94805

Sponsors and Collaborators

Gustave Roussy, Cancer Campus, Grand Paris

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Gustave Roussy, Cancer Campus, Grand Paris

ClinicalTrials.gov Identifier:

NCT01786031

Other Study ID Numbers:

2012-A00668-35

First Posted:

Feb 7, 2013

Last Update Posted:

Feb 8, 2016

Last Verified:

Feb 1, 2016

Additional relevant MeSH terms:

Prostatic Neoplasms

Study Results

No Results Posted as of Feb 8, 2016